Published: 2022-08-29

A comparative study of coagulation profile and platelet indices at term in pre-eclamptic, eclamptic and normal pregnancy along with fetomaternal outcome

Prachika Indora, Sudha Gandhi, Priya Agarwal


Background: Hypertensive disorders of pregnancy is reported to cause about 60-80% of maternal deaths. Platelet indices are biomarkers of platelet activation. Among these platelet indices, mean platelet volume (MPV), and platelet distribution width (PDW), platelet large cell ratio (PLCR) is a group of platelet parameters. When platelets are activated, they become larger in size which causes increased platelet indices such as MPV, PDW and PLCR. So, platelet indices can give an idea of platelet activation. A comparative study of coagulation profile and platelet indices at term in pre-eclamptic, eclamptic and normal pregnancy along with fetomaternal outcome.

Methods: This study was carried out in department of obstetrics and gynaecology in collaboration with department of pathology, Rabindranath Tagore Medical College (RNTMC), Udaipur. Cases were selected by systematic random sampling. Bleeding time (BT), clotting time (CT), prothrombin time (PT), mean platelet volume (MPV), platelet distribution width (PDW), and activated partial thromboplastin time (aPTT) to analyse hypertensive disorders in pregnancy (HDP) during the period January 2021 to December 2021.

Results: Significant difference was seen in bleeding time (seconds), prothrombin time (seconds), aPTT (seconds) between normal pregnancy as compared to pre-eclampsia and eclampsia. (p value <0.05). Patients’ admission in neonatal intensive care unit (NICU) was significantly higher in eclampsia (p<0.0001) and pre-eclampsia (p<0.0001) as compared to normal pregnancy (66.67%, 43.24% versus 2% respectively).

Conclusions: We conclude that coagulation profile like (BT, CT, PT, and aPTT), platelet counts along with platelet indices- MPV, PDW are useful markers, which were significantly raised in patients with preeclampsia and eclampsia. Platelet indices along with coagulation profile emerges as an important, simple, cost effective and effortless tool for predicting severity of pregnancy induced hypertension (PIH).




Full Text:



Medici M, Korevaar T, Schalekamp-Timmermans S, Gaillard R, de Rijke YB, Visser WE, et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab. 2014;99:2591-8.

Duley L. Maternal mortality associated with hypertensive disorder of pregnancy in Africa, Asia, Latin America and Caribbean. Br J Obstet Gynecol. 1992;99(7):547-53.

Armaly Z, Jadaon JE, Jabbour A, Abassi ZA. Preeclampsia: Novel mechanisms and potential therapeutic approaches. Front Physiol. 2018;9:973.

Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens Res. 2017;40:213-20.

Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:2301.

National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-226.

Aali BS, Ghafoorian J, Mohamed-Alizadeh S. Severe preeclampsia and eclampsia in Kerman, Iran: complications and outcomes. Med Sci Monit. 2004;10:163-7.

Lone FA, Malik S, Ajaz S, Malik LA, Dar MP. Evaluation of coagulation profile in patients with pregnancy induced hypertension in patients attending a tertiary care hospital in north India. Int J of Adv Res. 2018;6:501-6.

Manchanda J, Malik A. Study of platelet indices in pregnancy-induced hypertension. Med J Armed Forces India. 2020;76(2):161-5.

Thalor N, Singh K, Pujani M, Chauhan V, Agarwal C, Ahuja R. A correlation between platelet indices and preeclampsia. Hematol Transfus Cell Ther. 2019;41(2):129-33.

Mohapatra S, Pradhan BB, Satpathy UK, Mohanty A, Pattnaik JR. Platelet estimation: its prognostic value in pregnancy induced hypertension. Indian J Physiol Pharmacol. 2007;51(2):160-4.

Meena P, Gupta A, Meena S, Kalra R. A Comparative Study of Coagulation Profile in Pre-Eclamptic and Normotensive Pregnant Females. IOSR J Dent Med Sci. 2018;17(3):49-58.

Beckman Coulter LH 500. Coulter Corporation; Kobe. Operator's Manual Automated Hematology Analyzer. Japan. 2004.

Osselaer JC, Jamrt J, Scheiff JM. Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem. 1997;43:1072-6.

Haldar B, Barui G. Study of coagulation profile and platelet indices in pregnancy induced hypertension with special reference to preeclamptic and eclamptic patients. Int J Res Med Sci. 2020;8:1114-8.

Alkholy MA, Alaboudi R S, Alghasham M A, Iqbal J, Adam I. Platelet count and platelet indices in women with preeclampsia. Vascular Health Risk Manag. 2016;12:477-80.

Annam V, Srinivasa K, Yatnatti SK, Suresh DR. Evaluation of platelet indices and platelet counts and their significance in Pre eclampsia and eclampsia. Int J Biol Med Res. 2011;2(1):425-8.

Chaithra H, Ramesh S T, Riyaz Ahmad, A Comparative Study of Coagulation Profile and Haematological Parameters in Pregnancy Induced Hypertension (PIH). Trop J Pathol Microbiol. 2021;7(3):150-5.

Vijaya LC. Comparative Study of Coagulation Profile in Mild Pre-eclampsia, Severe Pre-eclampsia, and Eclampsia. Int J Sci Study. 2016;4(4)180-3.

Kumar PL, Nirmala T, Vani BR, Murthy Srinivasa V, Geetha RL. Study of coagulation profile in pregnancy induced hypertension (PIH). Indian J Pathol Oncol. 2015:2(1):1-6.

Chauhan P, Rawat U, Bisht V, Purohit RC. Comparison of coagulation profile in pre-eclamptic and eclamptic patients with normotensive pregnant patients. J Evol Med Dental Sci. 2014;3(12):3208-15.

Swetha AG, Puranik N, Kammar KF. A comparative study on coagulation profile and neutrophillymphocyte ratio in pregnancy-induced hypertension. Natl J Physiol Pharm Pharmacol. 2018;8(3):400-5with preeclampsia. Am J Obs Gyn. 1994;171:713-21.